| CAS 登录号 | 产品名称 | 分子式 |
|---|---|---|
| 862507-23-1 | 5-[2-(tert-Butyl)-4-(4-fluorophenyl)-1H-imidazol-5-yl]-3-(2,2-dimethylpropyl)-3H-imidazo[4,5-b]pyridin-2-amine methanesulfonate | C24H29FN6.2(CH4O3S) |
| 862508-03-0 | (5-Fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl)carbamic acid pentyl ester | C10H14FN3O3 |
| 862539-91-1 | 2-Methyl-4-fluorobenzyl bromide;1-(Bromomethyl)-4-fluoro-2-methylbenzene | C8H8BrF |
| 862574-88-7 | 1-(2,2-Difluorobenzodioxol-5-yl)cyclopropanecarboxylic acid | C11H8F2O4 |
| 862599-47-1 | Ethyl 2-chloro-oxazole-5-carboxylate;2-Chlorooxazole-5-carboxylic acid ethyl ester; Ethyl 2-chloro-1,3-oxazole-5-carboxylate | C6H6ClNO3 |
| 862723-42-0 | 1H-Indazole-5-boronic acid pinacol ester;5-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)-1H-indazole; Indazole-5-boronic acid pinacol ester | C13H17BN2O2 |
| 862731-66-6 | 1-Octyl-3-methylimidazolium bis(2,2,2-trifluoroacetyl)imide;1-Methyl-3-octyl-1H-imidazolium salt with 2,2,2-trifluoro-N-(trifluoroacetyl)acetamide | C12H23N2.C4F6NO2 |
| 862772-11-0 | Cyclo(L-arginylglycyl-L-alpha-aspartyl-D-phenylalanyl-L-cysteinyl) | C24H34N8O7S |
| 862847-75-4 | 7-Bromo-9,9,9',9'-tetraethyl-2,2'-bifluorene | C34H33Br |
| 862894-96-0 | Bortezomib Impurity 4;(S)-N-(1-(3-Methylbutanamido)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide | C19H22N4O3 |
| 862895-00-9 | Bortezomib Impurity 11;N-[(1S)-2-[[(1E)-3-Methyl-1-buten-1-yl]amino]-2-oxo-1-(phenylmethyl)ethyl]-2-pyrazinecarboxamide | C19H22N4O2 |
| 862901-87-9 | (alphaS)-alpha-([1,1'-Biphenyl]-4-yloxy)benzenepropanoic acid;LT 175 | C21H18O3 |
| 862996-27-8 | (2R,4S)-4-Hydroxy-1,2-pyrrolidinedicarboxylic acid bis(1,1-dimethylethyl) ester | C14H25NO5 |
| 863029-89-4 | 2-[[(4-Chloro-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-6-methoxy-1H-benzimidazole | C16H16ClN3O2S |
| 863031-21-4 | Azilsartan medoxomil;TAK 491; 1-[[2'-(2,5-Dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]methyl]-2-ethoxy-1H-benzimidazole-7-carboxylic acid (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester | C30H24N4O8 |
| 863031-24-7 | Azilsartan kamedoxomil;1-[[2'-(2,5-Dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]methyl]-2-ethoxy-1H-benzimidazole-7-carboxylic acid (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester potassium salt | C30H23N4O8.K |
| 863111-48-2 | 2-Bromo-5-chloro-4-(trifluoromethyl)benzenamine | C7H4BrClF3N |
| 863127-76-8 | (E)-N-(2-Chloro-6-methylphenyl)-3-ethoxyacrylamide;(2E)-N-(2-Chloro-6-methylphenyl)-3-ethoxy-2-propenamide | C12H14ClNO2 |
| 863127-77-9 | Dasatinib monohydrate;N-(2-Chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide monohydrate | C22H26ClN7O2S.H2O |
| 863238-73-7 | 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-trityl-1H-pyrazole | C28H29BN2O2 |
| 863239-60-5 | Glyco Obeticholic Acid;3a,7a-dihydroxy-6a ethyl-5b-cholan-24-ol ; (3R,5S,6R,7R,8S,9S,10S,13R,14S,17R)-6-ethyl-17-((R)-5-hydroxypentan-2-yl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-3,7-diol | C28H47NO5 |
| 863239-61-6 | Obeticholic acid metabolite UPF-1443;Tauro-Obeticholic Acid;2-[[(4R)-4-[(3R,5S,6R,7R,8S,9S,10S,13R,14S,17R)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonic acid | C28H49NO6S |
| 863248-20-8 | 3-Morpholinophenylboronic acid hydrochloride;[3-(4-Morpholinyl)phenyl]boronic acid hydrochloride | C10H14BNO3.HCl |
| 863304-76-1 | 4-(tert-Butoxycarbonylamino)bicyclo[2.2.2]octane-1-carboxylic acid | C14H23NO4 |
| 863323-03-9 | 1-Iodo-4-(1,1,2,2-tetrafluoroethoxy)benzene | C8H5F4IO |
| 863329-65-1 | (2'R)-2'-Deoxy-2'-fluoro-2'-methyluridine 3',5'-dibenzoate | C24H21FN2O7 |
| 863329-66-2 | (2'R)-2'-Deoxy-2'-fluoro-2'-methyluridine;RO 2433; PSI-6206; 1-((2R,3R,4R,5R)-3-Fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione | C10H13FN2O5 |
| 863377-22-4 | 3-Morpholinophenylboronic acid;[3-(4-Morpholinyl)phenyl]boronic acid | C10H14BNO3 |
| 863394-07-4 | Se-(Methyl)-selenocysteine hydrochloride | C4H9NO2Se.HCl |
| 863422-41-7 | 2-(Pyridazin-4-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | C10H15BN2O2 |
| 863492-35-7 | 2-Aminoquinoline-6-carboxylic acid benzyl ester | C17H14N2O2 |
| 863504-84-1 | tert-Butyl 3-aminopyrazole-1-carboxylate;3-Aminopyrazole-1-carboxylic acid tert-butyl ester; tert-Butyl 3-amino-1H-pyrazole-1-carboxylate | C8H13N3O2 |
| 863513-91-1 | Cebranopadol;(1alpha,4beta)-6'-Fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro[cyclohexane-1,1'(3'H)-pyrano[3,4-b]indol]-4-amine; GRT 6005 | C24H27FN2O |
| 863548-52-1 | 1-Methyl-1H-pyrazole-5-methanamine;1-(1-Methyl-1H-pyrazol-5-yl)methanamine | C5H9N3 |
| 863578-32-9 | (S)-1-N-Boc-3-(2-hydroxyethyl)piperidine;(S)-tert-Butyl 3-(2-hydroxyethyl)piperidine-1-carboxylate; (S)-3-(2-Hydroxy-ethyl)-piperidine-1-carboxylic acid tert-butyl ester | C12H23NO3 |
| 863643-48-5 | 4,4'-(1,8-Pyrenediyl)bis[2-methyl-3-butyn-2-ol] | C26H22O2 |
| 863659-88-5 | (1'S)-[1,3':1',1'':3'',1'''-Quaternaphthalene]-2',2''-diol | C40H26O2 |
| 863659-89-6 | (1'S)-[2,3':1',1'':3'',2'''-Quaternaphthalene]-2',2''-diol | C40H26O2 |
| 863753-30-4 | 2-Aminophenylboronic acid hydrochloride | C6H8BNO2.HCl |
| 863753-35-9 | 2-(tert-Butoxycarbonylamino)pyridine-3-boronic acid | C10H15BN2O4 |
| 863769-40-8 | 2-(4-Carboxyphenyl)-1-pyrrolidinecarboxylic acid 1-(1,1-dimethylethyl) ester | C16H21NO4 |
| 863774-58-7 | 2,3,4,6,7,8-Hexahydro-4-(3-hydroxyphenyl)-7,7-dimethyl-2-thioxo-5(1H)-quinazolinone;Dimethylenastron | C16H18N2O2S |
| 863786-01-0 | 6-Benzyloxy-4-chloroquinoline;4-Chloro-6-(phenylmethoxy)quinoline | C16H12ClNO |
| 863868-36-4 | 3,5-Difluorophenylboronic acid pinacol ester;2-(3,5-Difluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | C12H15BF2O2 |
| 863870-86-4 | 2-Chloro-3-fluorophenol | C6H4ClFO |
| 863870-87-5 | 3-Bromo-2-chlorophenol | C6H4BrClO |
| 863886-04-8 | 4-Amino-3-chloro-5-nitrobenzoic acid methyl ester | C8H7ClN2O4 |
| 863971-12-4 | MMAF-Ome;methyl (2S)-2-[[(2R,3R)-3-methoxy-3-[(2S)-1-[(3R,4S,5S)-3-methoxy-5-methyl-4-[methyl-[(2S)-3-methyl-2-[[(2S)-3-methyl-2-(methylamino)butanoyl]amino]butanoyl]amino]heptanoyl]pyrrolidin-2-yl]-2-methylpropanoyl]amino]-3-phenylpropanoate | C40H67N5O8 |
| 863971-62-4 | Carbonylchlorohydrido[6-(di-tert-butylphosphinomethyl)-2-(N,N-diethylaminomethyl)pyridine]ruthenium(II) | C20H36ClN2OPRu |
| 863971-63-5 | Milstein Catalyst;Carbonylhydrido[6-(di-tert-butylphosphinomethylene)-2-(N,N-diethylaminomethyl)-1,6-dihydropyridine]ruthenium(II) | C19H35N2PRu.CO |